Provided by Tiger Trade Technology Pte. Ltd.

Xenon Pharmaceuticals

60.56
-0.2100-0.35%
Post-market: 60.560.00000.00%19:30 EDT
Volume:628.83K
Turnover:38.08M
Market Cap:5.85B
PE:-12.87
High:61.05
Open:60.77
Low:60.00
Close:60.77
52wk High:72.66
52wk Low:35.60
Shares:96.64M
Float Shares:95.45M
Volume Ratio:0.88
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7061
EPS(LYR):-4.3646
ROE:-43.62%
ROA:-28.02%
PB:4.71
PE(LYR):-13.88

Loading ...

Mar 06, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2025

Major Issues Report

Form 8-K - Current report
Dec 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 05, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]